CHARLOTESVILLE, Va.--(BUSINESS WIRE)--LumaCyte, a leading innovator in advanced single cell analysis technology and instrumentation, is proud to announce the launch of their newly redesigned flagship Radiance® instrument to meet growing demand for Laser Force Cytology™ (LFC) precision analytics in space-constrained biomanufacturing facilities.

弗吉尼亚州夏洛茨维尔（BUSINESS WIRE）-LumaCyte是先进单细胞分析技术和仪器领域的领先创新者，很自豪地宣布推出新设计的旗舰Radiance®仪器，以满足对激光力细胞学日益增长的需求™ （LFC）空间受限生物制造设施的精确分析。

The half-sized compact design is new, occupying only 16 inches of bench space, but the underlying technology remains unchanged. Utilizing LFC, LumaCyte’s Radiance® platform instrument provides real-time, label-free, quantitative cell characterization analytics for better manufacturing controls. Transforming the status quo, this capability enables manufacturers and production scientists to rapidly assess the quality of cellular starting materials and precisely optimize key production processes when manufacturing complex lifesaving biotherapeutics.

半尺寸紧凑型设计是新的，只占用16英寸的工作台空间，但底层技术保持不变。利用LFC，LumaCyte的Radiance®平台仪器可提供实时，无标签，定量的细胞表征分析，以实现更好的制造控制。改变现状，这种能力使制造商和生产科学家能够在制造复杂的救生生物治疗药物时快速评估细胞起始材料的质量并精确优化关键生产工艺。

The more compact Radiance® instrument is not just a step forward; it's a leap towards the future of real-time precision cell-based production analytics, where these insights have the power to guide and accelerate the delivery of life-saving advanced therapies for patients..

更紧凑的Radiance®仪器不仅仅是向前迈出的一步；这是迈向基于实时精确细胞的生产分析的未来的飞跃，这些见解有助于指导和加速为患者提供挽救生命的先进疗法。。

Manufacturing advanced biotherapeutic products is fraught with challenges - from complexities in the highly variable starting materials, to the large biological variations that can occur during production, compounded by slow and imprecise legacy analytics. LumaCyte’s novel Radiance® instrument is a process analytical technology (PAT) that combines advanced optics and microfluidics to transform the field of single cell analysis, delivering real-time process and production answers, streamlining lengthy manufacturing steps, and significantly improving the likelihood of production and product success..

制造先进的生物治疗产品充满了挑战-从高度可变的起始材料的复杂性，到生产过程中可能发生的巨大生物变化，再加上缓慢而不精确的遗留分析。LumaCyte的新型Radiance®仪器是一种过程分析技术（PAT），结合了先进的光学和微流体技术，改变了单细胞分析领域，提供实时过程和生产答案，简化了冗长的制造步骤，并显着提高了生产的可能性和产品成功。。

The new Radiance® instrument stands poised to meet the growing demands for advanced analytics in manufacturing and production environments. Regulators are increasingly encouraging the adoption and implementation of novel real-time precision PAT analytics earlier in process development and manufacturing processes to improve production quality and product consistency.

新的Radiance®仪器有望满足制造和生产环境中对先进分析的不断增长的需求。监管机构越来越鼓励在流程开发和制造流程早期采用和实施新颖的实时精确PAT分析，以提高生产质量和产品一致性。

Radiance® users now have real-time production analytics at their fingertips that both inform and enable rapid optimization, making better process control and consistent production quality a reality, and now with a much smaller footprint..

Radiance®用户现在可以在指尖处进行实时生产分析，既可以提供信息又可以实现快速优化，从而实现更好的过程控制和一致的生产质量，并且占地面积更小。。

Sean Hart, PhD, LumaCyte CEO and CSO, emphasizes the significance of the new Radiance® instrument in addressing industry needs: 'We understand the challenges that our customers face in maximizing their lab space and ensuring compliance with evolving regulatory standards. The Radiance® instrument is a testament to LumaCyte's commitment to pushing the boundaries of single cell analysis, providing our customers with an analytical solution that delivers answers on demand.

Sean Hart博士，LumaCyte首席执行官和CSO强调新型Radiance®仪器在解决行业需求方面的重要性：“我们了解客户在最大限度地扩大实验室空间并确保遵守不断变化的监管标准方面面临的挑战。Radiance®仪器证明了LumaCyte致力于推动单细胞分析的界限，为客户提供按需提供答案的分析解决方案。

With this compact yet highly capable device, we aim to revolutionize how cell-based analytics are performed, offering our customers a more efficient and space-saving solution.'.

凭借这种紧凑而功能强大的设备，我们的目标是彻底改变基于细胞的分析方法，为客户提供更高效，更节省空间的解决方案。

Radiance® has already captured the attention of top biopharma and CDMO organizations worldwide, establishing itself as a pioneering tool across many analytical applications in vaccines, gene, and cell therapy manufacturing. As laboratories continue to look for powerful and space-saving process analytical technology solutions for cell health, potency, functionality and sterility, Radiance® offers all these capabilities in one instrument..

Radiance®已经引起了全球顶级生物制药和CDMO组织的关注，成为疫苗，基因和细胞疗法制造领域许多分析应用的先驱工具。随着实验室继续为细胞健康，效力，功能和无菌性寻找强大且节省空间的过程分析技术解决方案，Radiance®可在一台仪器中提供所有这些功能。。

Meret Gaugler, PhD, global life sciences investor and advisor, says: “LumaCyte’s technology is driving advanced, streamlined analytics to replace outdated and cumbersome assays. Radiance®’s more compact form factor could not have come at a better time. Cell and gene therapy manufacturing is moving past the growing pains of earlier generations and the field has matured to sufficient relevance for regulators to start setting more stringent standards in the use and adoption of cellular PATs.”.

全球生命科学投资者兼顾问Meret Gaugler博士，说：“LumaCyte的技术正在推动先进，简化的分析，以取代过时和繁琐的分析.Radiance®更紧凑的形状因子不可能在更好的时候出现。细胞和基因治疗制造正在超越前几代日益增长的痛苦，该领域已经成熟与监管机构开始在美国制定更严格标准的足够相关性e和采用蜂窝PAT。”。

For more information about Radiance® and its benefits, please visit www.lumacyte.com.

有关Radiance®及其优势的更多信息，请访问www.lumacyte.com。

About LumaCyte

关于LumaCyte

LumaCyte, Inc. is an advanced research and bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation where the use of antibody or genetic labeling is not required for cellular analysis. This revolutionary technology utilizes Laser Force Cytology™ (LFC™) to measure optical and fluidic forces within a microfluidic channel, quantitatively characterizing innate cellular responses of subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells; which can be used to measure cellular changes in response to their environment or treatment.

LumaCyte，Inc。是一家先进的研究和生物分析仪器公司，可生产无标记的单细胞分析仪器，其中细胞分析不需要使用抗体或遗传标记。这项革命性的技术利用激光力细胞学™ （LFC™) 测量微流体通道内的光学和流体力，纯粹基于细胞固有的生物物理和生物化学特性，定量表征细微表型变化的先天细胞反应；可用于测量响应其环境或治疗的细胞变化。

The univariate and multivariate nature of the data has enabled a host of big data strategies and cloud computing capabilities that drive advanced analytics, allowing a deeper understanding of cell based biological systems. Applications of LumaCyte's label-free platform technology include viral infectivity for vaccine development and manufacturing, cell health, activation, transfection and transduction analytics for cell and gene therapy development and production monitoring, CAR T-cell immunotherapy, iPSC differentiation, adventitious agent testing (AAT), infectious disease, and pre-clinical drug discovery, in addition to multiple applications across advanced therapy biomanufacturing for real-time quality control..

数据的单变量和多变量性质使得大量的大数据策略和云计算功能能够推动高级分析，从而更深入地了解基于细胞的生物系统。LumaCyte无标签平台技术的应用包括用于疫苗开发和制造的病毒感染性，用于细胞和基因治疗开发和生产监测的细胞健康，激活，转染和转导分析，CAR T细胞免疫治疗，iPSC分化，外来因子检测（AAT），传染病和临床前药物发现，除了跨先进疗法生物制造的多种应用，可实现实时质量控制。。

Innovate. Discover. Transform. ™

创新。发现。转换。™